Navigation Links
Chug a Chaga Beverage to Good Health This Holiday Season
Date:12/8/2008

LOS ANGELES, Dec. 8 /PRNewswire/ -- With Christmas, Hanukkah and New Year's Eve looming, Americans are preparing to set aside their healthy lifestyles in favor of indulging in all the gustatory festivities. Celebratory soft drinks and alcoholic beverages are loaded with empty calories at best and harmful ingredients at their worst. Sayan Health wants holiday revelers to drink to their good health this holiday season with a beverage that's actually healthy. The all-natural, caffeine-, gluten- and artificial-sweetener-free Sayan(TM) Chaga fills that toasting bill. Available in original, raspberry and peach varieties, this drink consists of wild, hand-picked herbs and berries that work in combination to help make the imbiber strong and healthy.

Sayan Health offers a healthy alternative to alcohol and sodas. From the wilderness of the Sayan Mountains of Siberia, the Chaga beverage is made from a rare herb that is hand-picked in the birch tree forests. Daily drinkers of this exotic brew have been documented to live 100 years. Indeed, as far back as 4,600 years ago, Chinese traditional medicine referred to Chaga as the "King of Herbs."

One of the most powerful, concentrated sources of antioxidants, Chaga is believed to improve health and slow the aging process. It accomplishes these much sought-after health benefits by protecting the body's cells from free- radical damage. In addition, it enhances the body's ability to adapt to stress and harmful chemical or biological substances.

Troy Seeley, President of Sayan Health, believes Chaga is filling a much needed void in the beverage industry. "We are proud to be able to address this market. With over 1,400 clinical and scientific research publications having supported Chaga's health claims over the last 40 years, our revolutionary drink is positioned to exact a breakthrough in individuals' way of life. If they haven't already, Sayan Chaga is a name people will
'/>"/>

SOURCE Sayan Health
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. AcroMetrix Announces Launch of PeliSpy Chagas Positive Control
2. Free Access to Literature Data on Chagas Disease Offered Online: Collaborative Drug Discovery, Inc. provides Neglected Disease researchers with archive mine and collaborate access to small molecule bioactivity SAR data on parasitic disease
3. Milk is One Beverage Jackson Cant Afford to Keep Off the Grocery List
4. Milk Is One Beverage Albuquerque Cant Afford to Keep Off the Grocery List
5. Integrated Beverage Group Launches Childrens Throat Cooler(R) in Canada
6. Integrated Beverage Group Launches Childrens Throat Cooler(R)
7. American Beverage Association Statement on Caffeinated Energy Drinks
8. Veteran of the Beverage Industry, Ken Sadowsky, Joins Millennium Biotechnologies Board of Directors
9. Beverage Industry Continues Cutting Calories in Schools, Delivering on Its Commitment to Change Beverage Mix
10. Weight gain in children has no association with sugar-sweetened beverage consumption
11. Kids Gulping Down More Sugary Beverages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Cambridge have discovered that the loss of a key segment ... the first study to show that this kind of genetic ... Nature . , The study, led by Dr Sadaf ... from the Wellcome Trust Sanger Institute, looked at 300 children ... genome looking for types of mutation known as copy number ...
(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... 2b 003-A1 study, known as the 003 trial, ... relapsed and refractory multiple myeloma patients. These data ... at the 51st annual meeting of the American ... in this trial is complete (n=269), and full ...
(Date:12/6/2009)... Disorders information and Treatment site www.sleeping-with-a-sleeping-disorder.com ... with herbal or natural sleep aids from around ... for a good cause. The submissions will be ... Aids ,Encyclopedia, by YOU, to be sold from ... will donate 100% of the proceeds ,from sales ...
(Date:12/5/2009)... 5 There have been significant scientific advances in ... to gain a better understanding of how certain diseases ... provide patients with the best care. Research presented today ... of Hematology explores optimal induction therapies for managing multiple ...
(Date:12/5/2009)... NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative ... Research presented today at the 51st Annual Meeting ... new treatment options and improved diagnostic methods for ... leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that ...
Breaking Medicine News(10 mins):Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9
... Patients with Adenocarcinoma or Large Cell Carcinoma Histologies Achieved, ... ALIMTA-based Regimen, INDIANAPOLIS, May 28 The type ... influence their treatment,regimen and, in turn, survival outcome according ... the Journal of Clinical Oncology. Publication of,the study was ...
... company says Testosterone,is just the lucky charm competitive poker ... signed an agreement with West Babylon,s,Gamma Labs, maker of ... Series of Poker sponsor in Las Vegas. The tournament ... Las Vegas from May 30 through,July 14., Gamma ...
... OrbusNeich today announced that it,has received approval from ... stent in Taiwan., The Genous stent is coated ... (EPCs) circulating in the bloodstream. When,attracted to the inner ... to,quickly form a healthy layer of endothelium that minimizes ...
... standards and the life style connected to them seem ... symptoms. This has lead to the assumption that the ... structures or to exogenous non-infectious proteins, i.e. allergens, when ... protect the individual from infections. , The European ...
... only are cheeks central to your face they are ... in Junes Plastic and Reconstructive Surgery, the official medical journal ... a deep fat compartment located within the cheek is vital ... volume to this fat compartment make the cheek more youthful, ...
... 2008, WHITE PLAINS, NY Cesarean sections account for nearly ... to an analysis of nine years of national birth data. ... of nearly 60,000 singleton preterm births and 92 percent of ... to research by investigators from the March of Dimes and ...
Other Medicine News:Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 2Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 3Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 4Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 5Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 6Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 7Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 8Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 9Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 10Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 11Health News:Gamma Labs to Boost Testosterone At World Series of Poker In Las Vegas 2Health News:OrbusNeich Receives Approval to Market Genous(TM) Bio-engineered R stent(TM) in Taiwan 2Health News:Researchers from 5 countries to test hygiene hypothesis with EU funding 2Health News:Key to Angelina-like cheeks? Add volume to deep fat compartment 2Health News:C-sections a critical factor in preterm birth increase 2
(Date:12/3/2009)... MADISON, N.J., Dec. 3 A genetic variation that ... life-threatening blood disorder if exposed to certain pharmaceutical therapies ... at cancer diagnostics leader Quest Diagnostics (NYSE: ... of Hematology (ASH) Annual Meeting and Exposition, December 5-8, ...
(Date:12/3/2009)... DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: ... a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ... and office space at The Landmark at Eastview campus in ... 2023. This lease of additional space was completed approximately two ...
(Date:12/3/2009)... California, December 3 , ... C Viral Replication, Thereby Significantly Reducing Hepatitis C,Virus in ... Virus , - SPC3649 Demonstrates ... Adverse Events in the Treated Animals - Signaling a ...
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5As Teens Plug In Parents Fret 59129 1As Teens Plug In Parents Fret 59129 2As Teens Plug In Parents Fret 59129 3Gross Germ Spreading Behaviors Remain the Norm Despite Flu Season Concerns 59124 1Gross Germ Spreading Behaviors Remain the Norm Despite Flu Season Concerns 59124 2Gross Germ Spreading Behaviors Remain the Norm Despite Flu Season Concerns 59124 3Electronic Payment Exchange Welcomes New Visa Best Practices for Data Field Encryption 59123 1Electronic Payment Exchange Welcomes New Visa Best Practices for Data Field Encryption 59123 2Electronic Payment Exchange Welcomes New Visa Best Practices for Data Field Encryption 59123 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: